[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 54.78%
YoY- 50.99%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 984,749 993,744 937,972 903,482 781,763 667,895 646,928 7.25%
PBT 63,668 62,781 46,529 70,573 41,172 32,758 44,521 6.14%
Tax -15,100 -20,178 -15,205 -25,435 -11,528 -8,931 -11,305 4.94%
NP 48,568 42,603 31,324 45,138 29,644 23,827 33,216 6.53%
-
NP to SH 48,011 42,192 30,636 44,398 29,404 24,054 32,219 6.87%
-
Tax Rate 23.72% 32.14% 32.68% 36.04% 28.00% 27.26% 25.39% -
Total Cost 936,181 951,141 906,648 858,344 752,119 644,068 613,712 7.28%
-
Net Worth 527,991 502,162 481,681 481,282 451,381 417,306 400,063 4.73%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 36,234 20,707 17,661 17,650 - 50,290 28,881 3.85%
Div Payout % 75.47% 49.08% 57.65% 39.76% - 209.07% 89.64% -
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 527,991 502,162 481,681 481,282 451,381 417,306 400,063 4.73%
NOSH 258,819 258,846 258,968 117,672 106,962 107,001 106,968 15.85%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 4.93% 4.29% 3.34% 5.00% 3.79% 3.57% 5.13% -
ROE 9.09% 8.40% 6.36% 9.22% 6.51% 5.76% 8.05% -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 380.48 383.91 362.20 767.79 730.88 624.19 604.78 -7.42%
EPS 18.55 16.30 11.83 37.73 27.49 22.48 30.12 -7.75%
DPS 14.00 8.00 6.82 15.00 0.00 47.00 27.00 -10.36%
NAPS 2.04 1.94 1.86 4.09 4.22 3.90 3.74 -9.60%
Adjusted Per Share Value based on latest NOSH - 117,700
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 68.33 68.95 65.08 62.69 54.24 46.34 44.89 7.24%
EPS 3.33 2.93 2.13 3.08 2.04 1.67 2.24 6.82%
DPS 2.51 1.44 1.23 1.22 0.00 3.49 2.00 3.85%
NAPS 0.3663 0.3484 0.3342 0.3339 0.3132 0.2895 0.2776 4.72%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 7.13 4.61 4.49 10.18 5.90 4.98 3.80 -
P/RPS 1.87 1.20 1.24 1.33 0.81 0.80 0.63 19.87%
P/EPS 38.44 28.28 37.95 26.98 21.46 22.15 12.62 20.38%
EY 2.60 3.54 2.63 3.71 4.66 4.51 7.93 -16.95%
DY 1.96 1.74 1.52 1.47 0.00 9.44 7.11 -19.31%
P/NAPS 3.50 2.38 2.41 2.49 1.40 1.28 1.02 22.80%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 -
Price 5.65 4.62 4.66 8.83 5.90 4.95 4.00 -
P/RPS 1.48 1.20 1.29 1.15 0.81 0.79 0.66 14.40%
P/EPS 30.46 28.34 39.39 23.40 21.46 22.02 13.28 14.83%
EY 3.28 3.53 2.54 4.27 4.66 4.54 7.53 -12.92%
DY 2.48 1.73 1.46 1.70 0.00 9.49 6.75 -15.36%
P/NAPS 2.77 2.38 2.51 2.16 1.40 1.27 1.07 17.17%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment